The Guardian newspaper just published an article about a groundbreaking new study that has found that medical cannabis might do more than ease symptoms — it may actually help treat cancer. Let’s explore what that could mean, and where CBD fits into the picture.
The Guardian article referenced a new US-based study published in BMJ Supportive & Palliative Care that has caught global attention — and for good reason. The researchers tracked nearly 3,000 cancer patients who were prescribed medical cannabis and found something remarkable.
Not only did patients report better sleep, reduced anxiety, and less pain, but the study also suggests that medical cannabis might play an active role in treating cancer itself.
“The findings raise hopes that cannabinoids may slow or stop tumour growth in certain cancers,” the researchers noted.
Where does CBD fit into all of this?
The study looked at medical cannabis, which often contains THC – the compound that causes a “high”. But for many in the UK and elsewhere, CBD (Cannabidiol) remains the more accessible and legal option.
And while CBD doesn’t have the intoxicating effects of THC, it still has a wide range of potential therapeutic benefits, many of which could be highly relevant for people undergoing cancer treatment.
At Bristol CBD, we’ve supported hundreds of customers who’ve used CBD oils, pastes, and functional mushroom tinctures alongside medical treatment to:
- 🌿 Support their immune system
- 😴 Improve sleep and restfulness
- 💪 Maintain energy and strength
- 🧘♀️ Manage anxiety and mood swings
- 🔥 Reduce inflammation and discomfort
What makes CBD promising for cancer support?
CBD interacts with the endocannabinoid system, which plays a key role in regulating immune response, pain, mood, and sleep.
While more research is needed, existing studies and user experiences suggest CBD may offer:
- ✅ Anti-inflammatory properties
- ✅ Anti-anxiety and mood-regulating effects
- ✅ Neuroprotective support
- ✅ Wellbeing benefits without intoxication
Some studies even suggest CBD may inhibit tumour cell growth, particularly when used alongside other cannabinoids — though more research is needed in this area before any firm conclusions can be drawn.
Research highlights for CBD and cancer:
While not a cure, CBD is being studied for its potential in cancer support:
🔬 A 2019 review in Cancers journal found CBD may promote cancer cell death in preclinical studies while improving quality of life during treatment. 👉 View study in Cancers journal (2019)
🔬 A 2020 Frontiers in Pharmacology review suggested that CBD may enhance the effects of chemotherapy and protect against nerve damage. 👉 View study in Frontiers (2024)
🔬 Studies have also looked at the anti-inflammatory and anti-tumour potential of combining CBD with other natural compounds. 👉 See study on CBD & immune modulation (2020)
In addition an article titled “Should Oncologists Trust Cannabinoids?” published in Frontiers in Pharmacology provides a comprehensive review of the current evidence regarding the use of cannabinoids in oncology. It discusses the potential benefits, limitations, and the need for further research in this area.
Key Points from Should Oncologists Trust Cannabinoids?:
- Pain Management: Cannabinoids, particularly Δ9-THC, may have an opioid-sparing effect, potentially reducing the required dosage of opioids for pain relief in cancer patients.
- Chemotherapy-Induced Nausea and Vomiting (CINV): Cannabinoids have shown efficacy in managing CINV, with some studies indicating they may be more effective than traditional antiemetics in certain cases.
- Chemotherapy-Induced Peripheral Neuropathy (CIPN): Preclinical studies suggest that cannabinoids may offer neuroprotective benefits against CIPN, though clinical evidence is still limited.
- Cancer Cachexia: While cannabinoids have been explored for appetite stimulation in cancer cachexia, results are mixed, and more robust clinical trials are needed to establish efficacy.
- Antitumor Effects: Preclinical studies have demonstrated that cannabinoids can inhibit tumor growth and induce apoptosis in various cancer cell lines. However, translating these findings into clinical practice requires more extensive human studies.
A gentle option with powerful potential
For people looking for natural, supportive care alongside traditional treatments, CBD can be a gentle, accessible option — especially when paired with powerful allies like Turkey Tail, Reishi, and other functional mushrooms.
It’s important to remember:
🔹 CBD is not a cure for cancer.
🔹 But it may help improve quality of life, and possibly more.
As research evolves, so does hope.
Want to try CBD or learn more?
We’re here to help. Call us on 07706 031 935 or email us at info@bristolcbd.co.uk at any time. If you or someone you love is exploring natural support alongside cancer treatment, feel free to reach out. We’ll listen, answer your questions, and help you choose what feels right for your body and journey.
About Bristol CBD:
Bristol CBD is the most trusted CBD brand in the UK with a trust score of 5.0 stars on both Google and Trustpilot. As well as CBD products, Bristol CBD also sell high-spec functional mushrooms including Lion’s Mane, Cordyceps, Shiitake, Chaga, Reishi and Turkey Tail.
We offer unparalleled customer service, support, guidance and advice and a 100% money back guarantee if you are not entirely satisfied with your product.
If you have any questions about how to buy or use CBD or medicinal mushroom products, please feel free to call us on 07706 031 935 or email us at info@bristolcbd.co.uk at any time. We are always happy to share our experiences and help people to find the best solution for their own needs.
Please note that Bristol CBD staff are not qualified doctors or nurses and therefore we do not make any medical claims and cannot recommend CBD for specific ailments. Our articles are simply based on our own research and over 12 years experience of working with CBD and other supplements. We always encourage people to talk with their GPs, physicians or nurses before taking CBD products.